| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.05 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |